Business Context and Reporting Period
This Form 8-K is filed by TransBiotec, Inc. (not SOBR Safe, Inc.) on January 22, 2013, reporting events occurring between December 21, 2012, and December 28, 2012. The company is a Delaware corporation headquartered in Long Beach, California.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and legal contingencies.
Material Changes
- Executive Departure: Scott Painter was terminated as Chief Executive Officer effective December 28, 2012. No immediate replacement was appointed.
- Interim Leadership: Charles Bennington, the company's President, assumed the responsibilities of the CEO pending a search for a permanent successor.
- Legal Action: On December 21, 2012, the company was served with an involuntary Chapter 7 bankruptcy petition filed by creditor Bill Bowman against TransBiotec, Inc., a wholly-owned California subsidiary.
Outlook, Risks, and Management Commentary
Management states the involuntary bankruptcy petition is without merit and fails to meet mandatory filing requirements. The company intends to oppose the petition to the fullest extent permitted by law. Additionally, the company is engaged in settlement discussions with the petitioning creditor, Bill Bowman. A successful settlement would result in the withdrawal and dismissal of the bankruptcy action.
Investor Verification Checklist
- Verify the status of the involuntary Chapter 7 bankruptcy petition against the wholly-owned subsidiary.
- Confirm the progress of settlement negotiations with creditor Bill Bowman.
- Monitor the timeline for the appointment of a permanent Chief Executive Officer.
- Review subsequent filings for any updates on the company's liquidity position given the bankruptcy threat.